CoDon AG banner

Intrinsic Value

Not Available for CNW

There is not enough data to reliably calculate the intrinsic value for CoDon AG.

Do our valuations actually work? See backtest results .

Alternatives to CNW

Fundamental Analysis

What CoDon Does

Biotechnology Health Care

co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage defects. The firm develops, produces, and distributes autologous cell therapies for the minimally invasive repair of cartilage defects, it manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal cartilage defects, lumbar disc herniation, non-union fractures, and dental disorders.

Headquarters
Germany DE
Employees
134
IPO date
Feb 1, 2001
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue CNW Research

Decided on CoDon? Get an email when CNW reaches the price you’d buy at. Free with an account.

Other CoDon listings

Back to Top